SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: LEO RISHTY who wrote (3700)7/13/1998 7:36:00 PM
From: Jonathan Schonsheck  Read Replies (3) of 4342
 
Dear Leo,

Let us suppose that the worldwide agreement merely doubles the projected (minimum) North American revenues from the BioFIT program through Scherer. (Recall that these revenues are from BioFIT only; there is - as yet - no mention of revenues from products.)

What is the appropriate "multiple"? What sort of market capitalization and share price should one expect regarding a company with revenues on this scale?

Jonathan

Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News